Selected article for: "drug toxicity and long term"

Author: Shapira, Assaf; Benhar, Itai
Title: Toxin-Based Therapeutic Approaches
  • Document date: 2010_10_28
  • ID: 00cf294x_49
    Snippet: Treatment with PA-L1/LF also delayed tumor growth and improved long-term survival in mice with orthotopically implanted anaplastic thyroid carcinoma (ATC) xenografts. The antitumorogenic effect was comparable with that achieved by the multikinase inhibitor, sorafenib, which is currently under evaluation for clinical use in patients with papillary thyroid carcinoma (PTC). As was already found in previous studies [422, 423] , the therapeutic effect.....
    Document: Treatment with PA-L1/LF also delayed tumor growth and improved long-term survival in mice with orthotopically implanted anaplastic thyroid carcinoma (ATC) xenografts. The antitumorogenic effect was comparable with that achieved by the multikinase inhibitor, sorafenib, which is currently under evaluation for clinical use in patients with papillary thyroid carcinoma (PTC). As was already found in previous studies [422, 423] , the therapeutic effect of PA-L1/LF was mediated by the potent antiangiogenic activity of the drug, which did not cause any significant systemic toxicity [424] .

    Search related documents:
    Co phrase search for related documents
    • anaplastic thyroid carcinoma and long term survival: 1
    • anaplastic thyroid carcinoma and thyroid carcinoma: 1, 2, 3, 4
    • long term and papillary thyroid carcinoma: 1, 2, 3
    • long term and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • long term and PTC papillary thyroid carcinoma: 1
    • long term and systemic toxicity: 1, 2, 3, 4, 5
    • long term and therapeutic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • long term and thyroid carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • long term and tumor growth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • long term survival and systemic toxicity: 1
    • long term survival and therapeutic effect: 1, 2
    • long term survival and thyroid carcinoma: 1, 2
    • long term survival and tumor growth: 1, 2
    • papillary thyroid carcinoma and PTC papillary thyroid carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • papillary thyroid carcinoma and thyroid carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • papillary thyroid carcinoma and tumor growth: 1
    • previous study and therapeutic effect: 1, 2, 3
    • previous study and tumor growth: 1
    • PTC papillary thyroid carcinoma and thyroid carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13